SkyAI, Inc.

NASDAQ:STSS

Medical - Instruments & Supplies

Healthcare
$1.32 +0.00%

+$0.00 today

Market cap
$55.65M
Beta
2.02
P/E (TTM)
1.3
EPS (TTM)
$0.91
52W Low $1.09High $18.23

Volume 0.00M

Average 0.37M

STSS EBITDA Margin

EBITDA as a percentage of revenue.

SkyAI, Inc.NASDAQ: STSS

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin at -44722.9%

EBITDA Margin was -44722.9% in Q1 FY2026. On a trailing-twelve-month basis it was -86155.0%.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 60.0% for the fiscal year ending Dec 2026, up from -132145.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-44722.9%-195611.5 pp QoQ
Last fiscal yearDec 2025
-132145.5%— YoY
LTMMar 2026
-86155.0%— YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year—+132205.5 pp—
3 years———
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-132145.5%
Year-over-year change
—
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How STSS compares with its peers on the latest reported figures

  • STSS's LTM Mar 2026 EBITDA Margin of -86155.0% is the lowest of the 8 companies compared; the peer median is -131.2%.
STSS Competitors Peer median
EBITDA Margin for STSS and competitors
Company Period LTM level YoY 3-year change
PDEXPro-Dex, Inc.LTM Mar 202626.3% +4.7 pp+4.8 pp
CCLDCareCloud, Inc.LTM Mar 202622.8% +1.3 pp+8.3 pp
JYNTThe Joint Corp.LTM Mar 20265.2% +4.5 pp-5.1 pp
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026-131.2% +8.9 pp+214.5 pp
LUCDLucid Diagnostics Inc.LTM Mar 2026-859.3% +600.4 pp+13170.1 pp
MBOTMicrobot Medical Inc.LTM Mar 2026-13493.3% ——
SERASera Prognostics, Inc.LTM Mar 2026-54764.9% -26826.7 pp-22063.2 pp
STSSSkyAI, Inc.LTM Mar 2026-86155.0% ——
GLSIGreenwich LifeSciences, Inc.FY2025— ——
CGTXCognition Therapeutics, Inc.FY2025— ——
Peer median (excluding STSS) -131.2%+4.6 pp+6.6 pp

Competitors are the stored peer set for STSS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000204.12K
Cost of Revenue28.7K654.57K891.25K773.9K617.45K
Gross Profit(28.7K)(654.57K)(891.25K)(773.9K)(413.33K)
Gross Margin————-202.5%
Research & Development1.69M1.63M729.48K(58.03K)198.76K
Selling, General & Admin2.78M6.45M8.52M7.14M19.49M
Operating Expenses4.47M8.08M9.24M7.08M12.88M
Depreciation & Amortization28.7K654.57K891.25K773.9K132.54K
EBITDA(4.47M)(2.66M)(8.98M)(6.85M)(269.74M)
EBITDA Margin————-132145.5%
Operating Income(4.5M)(8.74M)(10.13M)(7.86M)(13.29M)
Operating Margin————-6512.1%
Interest Income7691.32K138.12K40.3K0
Interest Expense167.52K1.32M01.71M416.66K
Other Income / Expenses(166.75K)4.1M255.01K(1.47M)(257.04M)
Income Before Tax(4.66M)(4.64M)(9.87M)(9.33M)(270.34M)
Pre-Tax Margin————-132439.5%
Income Tax Expense00(30K)(30K)0
Net Income(4.66M)(4.64M)(9.84M)(9.3M)(282.5M)
Net Margin————-138400.0%
EPS (Basic)(3,356.30)(3,780.28)(4,983.99)(2,220.05)(11.16)
EPS (Diluted)(3,356.30)(3,780.28)(4,983.99)(2,220.05)(11.16)
Weighted Avg Shares1.39K1.23K1.97K4.19K25.31M
Weighted Avg Shares (Diluted)1.39K1.23K1.97K4.19K25.31M

SkyAI, Inc.

NASDAQ:STSS

Intrinsic Alpha fair value

Locked

Current Price

$1.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.